A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/29/2006	CN1286463C Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof
11/29/2006	CN1286462C Medical preparation for injection
11/29/2006	CN1286461C Spray containing molsidomine
11/29/2006	CN1286460C Application of sophocarpine on preparing medication for curing disease caused by coronavirus
11/29/2006	CN1286459C Transparent and disappearing external medicine preparation containing benzotolazo
11/29/2006	CN1286458C Application of cnidium fruit element in the preparing process of medicine for preventing and treating Sexual dysfunction
11/29/2006	CN1286457C Freeze-dried powder injection of andrographolide and preparation thereof
11/29/2006	CN1286456C Luolai compositions useful for the treatment of type-2 synalbumin diabetes pharmaceutical application
11/29/2006	CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural
11/29/2006	CN1286454C Method for preparing controllable complex of taxiol and polylactic acid
11/29/2006	CN1286451C Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof
11/29/2006	CA2558704A1 Use of paliperidone for the treatment of sleep disturbances and/or excessive daytime sleepiness in psychiatric patients
11/28/2006	US7142910 Methods of indirectly stimulating the vagus nerve with an electrical field
11/28/2006	US7141696 N-alkyl-diphenyl-alkylene-amine derivatives; for the treatment of smooth muscle hyperactivity in urinary incontinence, gastrointestinal disorder, respiratory system disorder; promoting smooth muscle relaxation, reducing hypotension or cardiac side effects
11/28/2006	US7141691 Derivatives of carboplatin with fewer undesired side-effects and higher efficacy towards tumor tissue; for treatment of cancer
11/28/2006	US7141674 Anti-inflammatory compounds
11/28/2006	US7141671 Biphenyl derivatives
11/28/2006	US7141660 Genes encoding a nystatin polyketide synthase and their manipulation and utility
11/28/2006	US7141658 Nucleotide sequences in the rpoB gene of spirochetes code for the beta subunit of the bacterial RNA polymerase; amplification, sequencing and comparison; complexing with genetic probes
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141611 An anticholesterol agents, for lowing LDL-cholesterol and increasing HDL-cholesterol, preventing hypercholesterolemia, cardiovascular disorders; comprising eicosanol, docosanol, tetracosanol, hexacosanol, heptacosanol, octacosanol
11/28/2006	US7141610 Using glycol ether to detach retinal tissue
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	US7141607 Topically administering Hydroxamic acid matrix metalloproteinase inhibitors such as batimastat to the eye
11/28/2006	US7141606 Muscle relaxation; brain disorders; antiepileptic agents
11/28/2006	US7141604 Administering to a patient citalopram or salts to treat hypertension and hypotension
11/28/2006	US7141603 Ketospirocyclopropaneindene compounds; anticarcinogenic agents
11/28/2006	US7141602 Process for obtaining HMG-CoA reductase inhibitors of high purity
11/28/2006	US7141601 Applying to the skin a 5,7-dihydroxy-3-[(4-methoxyphenyl)methyl]-6,8-dimethyl-chroman-4-on (methylophiopogonanone B ) for reducing dyschromatosis on which tyrosinase inhibitors have insufficient effect
11/28/2006	US7141600 Small molecule inhibition of a PDZ-domain interaction
11/28/2006	US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006	US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006	US7141597 1 ((+)-(S)-4-[1-(2,3-dimethyl-phenyl)-ethyl]-1-1,3-dihydro-imidazole-2-thione) for treatment of chronical pain, diabetes, hyperglycemia, hypertriglyeridemia, decreased levels of blood insulin and hyperlipidemia
11/28/2006	US7141596 Inhibitors of proteins that bind phosphorylated molecules
11/28/2006	US7141595 Amino benzothiazole compounds with NOS inhibitory activity
11/28/2006	US7141594 inhibitors of HIV protease for treating AIDS
11/28/2006	US7141593 Pharmaceutical formulations
11/28/2006	US7141592 Substituted oxadiazolidinediones
11/28/2006	US7141591 e.g., 2-methyl-2-{4-[3-(4-tert-Butyl-phenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-2-methyl-phenoxy}propionic acid or its ethyl ester; dyslipidemia, syndrome X, heart failure, hypercholesteremia, cardiovascular disease, diabetes, anorexia, etc.
11/28/2006	US7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
11/28/2006	US7141589 Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation
11/28/2006	US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006	US7141587 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/28/2006	US7141586 Nicotinamide derivatives useful as PDE4 inhibitors
11/28/2006	US7141585 Pyrazole derivatives
11/28/2006	US7141584 2-(substituted-phenyl)amino-imidazoline derivatives
11/28/2006	US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/28/2006	US7141582 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders
11/28/2006	US7141581 Modulates and/or inhibits tyrosine kinase signal transduction; antiproliferative agents; treating, prevention of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141579 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
11/28/2006	US7141578 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
11/28/2006	US7141577 Antitumor agents
11/28/2006	US7141576 4-quinazolineamine derivatives; antineoplastic agents; inhibitors of erb family tyrosine kinases and/or epidermal growth factor receptors
11/28/2006	US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141571 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/28/2006	US7141570 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
11/28/2006	US7141569 Antiviral pyrazolopyridine compounds
11/28/2006	US7141568 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/28/2006	US7141567 such as (7R,8R,9R)-8-hydroxy-2-methyl-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine; for treatment of gastrointestinal disorders
11/28/2006	US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006	US7141565 Substituted quinobenzoxazine analogs
11/28/2006	US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006	US7141563 Used for prophylaxis and therapy of central nervous system disorders, including obsessive-compulsive disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, panic disorder, migraine, sleep disorders
11/28/2006	US7141562 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	US7141560 For use as analgesic or sedative; treating sleep disorders
11/28/2006	US7141559 Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141557 Lipid analogs for treating viral infections
11/28/2006	US7141556 Process for the preparation of glucosamine salts
11/28/2006	US7141555 Water solubility, bioavailability, oral administration; unit dosage
11/28/2006	US7141554 Method of treating irritable bowel syndrome
11/28/2006	US7141553 A3AR agonists for the treatment of inflammatory arthritis
11/28/2006	US7141552 Use of lipid conjugates in the treatment of diseases
11/28/2006	US7141551 Perlacan (proteoglycan); administered internally or topically, or is expressed from exogenously added nucleic acids; surgery
11/28/2006	US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules
11/28/2006	US7141548 controlling dietetic fats and,or antilipemic agents ; reducing blood lipid concentration
11/28/2006	US7141542 Biologically active protein useful for aerosol delivery to the respiratory tract
11/28/2006	US7141540 Used as bioactive agent carriers for drug delivery of paclitaxel
11/28/2006	US7141434 Utilizing an adenosine kinase as a surrogate analyte; methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts
11/28/2006	US7141428 Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
11/28/2006	US7141409 Hyaluronan synthase gene and uses thereof
11/28/2006	US7141254 Trigonelline from Fenugreek, amino acids and soluble fiber
11/28/2006	US7141253 Cyclooxygenase-2 inhibitory withanolide compositions and method
11/28/2006	US7141252 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
11/28/2006	US7141251 Pharmacologically active strong acid solutions
11/28/2006	US7141249 Rapidly soluble drug composition
11/28/2006	US7141247 Intravenous valproate for acute treatment of migraine headache
11/28/2006	US7141246 adheres to a wide variety of substrates and resists wet abrasion; biocompatible; stability
11/28/2006	US7141238 Compositions for reducing UV-induced inhibition of collagen biosynthesis in human skin
11/28/2006	US7141237 Pharmaceutical foam
11/28/2006	US7141045 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
11/28/2006	US7140882 Preparation of low molecular weight chitin/chitosan; obtain chitin/chitosan sample, irradiate with gama radiation, separate decompose and recover low molecular weight chitin/chitosan
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2378007C Benzimidazole compounds

1 ... 3991 3992 3993 3994 3995 3996 3997 3998 3999 4000 4001 4002 4003 4004 4005 4006 4007 4008 4009 4010 4011 ... 7860